The world’s first multi-modality AI-powered worklist is now available to EU hospitals via Zebra Medical Vision

Clean Sweep Live Auction on Wed. Mar. 11th. Click to view the full inventory

The world’s first multi-modality AI-powered worklist is now available to EU hospitals via Zebra Medical Vision

Press releases may be edited for formatting or style | February 28, 2019 Artificial Intelligence

“In a clinical validation study we performed, Zebra-med’s acute CXR pneumothorax and CT brain bleed products demonstrated a promising potential to substantially reduce turn around time and increase the radiologist's confidence in making these diagnoses,” said Dr. Terence Matalon, MD, FACR, FSIR Chairman, Diagnostic Radiology at Albert Einstein Medical Center. "Seeing the software in action emphasized key aspects AI solutions must address in order impact our field: high accuracy, speed, seamless integration to our workflow, and the ability to work on multi modalities - both X-ray and CT."

“Our acute-findings line of products emphasizes the Zebra Medical Vision team’s dedication to providing AI solutions to the majority of radiology departments worldwide who are reading and reporting more than just one modality,” says Eyal Gura, Zebra-Med’s CEO and Co-Founder. “We are thrilled to make this solution available today to hospitals across Europe that work with the many PACS and worklist systems that already integrate Zebra-Med’s software.”

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.


Zebra-Med works with some of the world’s leading health providers, which together operate over 100 hospitals. Last year, Zebra-MEd received 8 CE marks for various algorithms and 510(k) FDA clearance for its Coronary Calcium Scoring algorithm, expanding company’s footprint in the US. In addition to the recently announced Israel Innovation Authority grants, Zebra-Med has raised over $50 million from a range of investors over three funding rounds.

*The acute-findings solutions are available for sale in the European Union, 510(k)-pending. Not available for sale in the USA.


About Zebra Medical Vision
Zebra Medical Vision uses deep learning to create and provide next generation products and services to the healthcare industry. Its Imaging Analytics Platform allows healthcare institutions to identify patients at risk of disease, and offer improved, preventative treatment pathways to improve patient care. Headquartered in Kibbutz Shefayim Israel, Zebra was founded in 2014 by Co-Founders Eyal Toledano, Eyal Gura, and Elad Benjamin and funded by Khosla Ventures, Marc Benioff, Intermountain Investment Fund, OurCrowd Qure, Aurum, aMoon, Nvidia, J&J, and Dolby Ventures. For more information, visit www.zebra-med.com.

Back to HCB News

You Must Be Logged In To Post A Comment